erythropoietin alfa Injection, pre-filled syringe 2000 IU, 4000 IU, 10000 IU - 0.5 ml, 1 ml

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Unavailable markets
Manufacturer #1535

Manufacturer usually replies in 16 days

Erythropoietin Alfa

Erythropoietin is a therapeutic agent used in treating anemia resulting from chronic kidney disease and myelodysplasia, from the treatment of cancer like chemotherapy and radiation. It is produced by recombinant DNA technology in mammalian cell culture. It treats anemia by increasing the red blood cell count in people with long-term serious chronic kidney failure, or people getting treated for HIV with zidovudine, and chemotherapy for cancer that does not involve the bone marrow or blood cells. Erythropoietin Alfa is given to anemic patients to reduce the need for blood transfusions before some kinds of planned surgeries with a high risk of blood loss Epoetin alfa actions amek the bone marrow produces more red blood cells. Epoetin alfa is human erythropoietin that was authorized by the European Medicines Agency in 2007 to stimulate erythropoiesis and to treat anemia, associated with chronic kidney failure and cancer chemotherapy. Amgen manufactured is under the name Epogen, J& J sells it as Procrit, pursuant to a product license agreement.

Dosage Forms & administration

Epoetin alfa is sold as an injectable solution in concentrations from 2000 units/mL, 3000 units/mL, 4000 units/MLM 10,000 units/mL, 20,000 units/mL and 40,000 units/mL. in the treatment of Patients with CKD on dialysis, the treatment is initiated when hemoglobin level drops below <10 g/dL. If its level approaches or >11 g/dL, the user can reduce the dose. The initial dose is 50-100 units/kg, given through an IV, three times a day. In the treatment of anemia due to HIV treatment with zidovudine at <4200 mg for the week are given the endogenous serum of <500 milliunits/mL followed by 100 units/kg, 3 times weekly. If HBG levels don’t improve in 8 weeks, the dose is increased by 50-100 units for kg, every 1-2 months until hemoglobin reaches a level sufficient to avoid RBC transfusions. This medication should be taken closely in relation to the HBG levels in consultation with your doctors.

The Cost of Epoetin Alfa

For years, this medicine cost the US Government, nearly USD 2 billion in making this medicine affordable. However, the cost has now come down, wherein in the USA, The consumer cost for the injectable solution of 2000 units/mL is USD $356 for a supply of 10 milliliters. However, it is much cheaper in the developing world. In India, a vial containing 4000IU Inj costs only around USD 12 and can be as high as USD 20.

How does Epoetin Alfa Work?

Erythropoietin is a glycoprotein. Its role is to regulate the production of red blood cells by stimulating the division and differentiation of committed erythroid progenitor cells in the bone marrow. Epoetin Alfa is made using recombinant DNA technology in mammalian cell culture. It works by increasing the red blood cells.

Finding Erythropoietin Alfa Manufacturers and Suppliers

The best way to find and gain access to Erythropoietin Alfa manufacturers and Erythropoietin Alfa suppliers are to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Erythropoietin Alfa can be a time-consuming challenge, but with Pipelinepharma's simple search engine and a network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Erythropoietin Alfa to work with. You can find- tune your search results using various filters too, letting you search for Erythropoietin Alfa from specific countries.